Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA for Chemotherapy-Induced Cognitive Dysfunction
NCT02517502Phase 1Completed
- Start
- Jul 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cognitive dysfunction comparing DHA with Placebo (2 arms). Primary endpoints: Trial acceptance at 12 months, Subject retention and trial completion at 12 months and 2 more. Started Jul 2015; status: completed.
02
Drugs
docosahexaenoic acid
03
Conditions
cognitive dysfunction
Beyond the preview
Go deeper on NCT02517502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517502.